Early and mid-term outcomes of transcatheter closure of perimembranous ventricular septal defects using the Lifetech™ Konar-MF Occluder device (MFO).

Published in: Cardiology in the young (2022)

This study showed that MFO is a safe and effective device in the transcatheter treatment of perimembraneous ventricular septal defect's with mid-term follow-up.

Keyphrases

heart failure
left ventricular
catheter ablation
type diabetes
adipose tissue
metabolic syndrome
insulin resistance
glycemic control